Casey A Walsh1,2, Jean C Yi2, Abby R Rosenberg3,4,5,6, Marie-Laure V Crouch2, Wendy M Leisenring2, Karen L Syrjala2,7. 1. Department of Health Services, University of Washington, Seattle, Washington, USA. 2. Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. 3. Cancer and Blood Disorders Center, Seattle Children's Hospital, Seattle, Washington, USA. 4. Center for Clinical and Translational Research, Palliative Care and Resilience Research Program, Seattle Children's Research Institute, Seattle, Washington, USA. 5. University of Washington, Cambia Palliative Care Center of Excellence, Seattle, Washington, USA. 6. Department of Pediatrics, School of Medicine, University of Washington, Seattle, Washington, USA. 7. Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Washington, Seattle, Washington, USA.
Abstract
OBJECTIVE: Hematopoietic stem cell transplantation (HSCT) can compromise long-term health and social functioning. We examined the impact of physical and social-emotional factors on the social functioning of long-term adolescent and young adult (AYA) HSCT survivors. METHODS: This cross-sectional analysis included HSCT recipients from the INSPIRE trial [NCT00799461] who received their first transplant between ages 15-39. Patient-reported outcome measures included the Short Form-36v2, Fatigue Symptom Inventory, Cancer and Treatment Distress, and the ENRICHD Social Support Inventory. We used hierarchical multiple linear regression to identify physical and social-emotional factors associated with social functioning at the baseline assessment, with the first block including sociodemographic and clinical factors significant at P = <0.10 in univariate testing, the second block including fatigue and physical function, and the third block including social support and distress. RESULTS: Participants (N = 279) were 52% male and 93.5% white, non-Hispanic, with a mean age of 30.3 (SD 6.6) at first transplant. Social Functioning mean was 48.5 (SD 10.5), below age-adjusted norms (t = -13.6, P = <0.001). In the first block, current chronic graft-vs-host disease accounted for 5.5% of the variance (P = <0.001). Adding fatigue and physical function explained an additional 46.6% of the variance (P = <0.001). Adding distress and social support explained an additional 7.7% of the variance (P = <0.001). The final model explained 59.8% of the variance; distress, fatigue, and physical function were significantly associated with social functioning. CONCLUSIONS: Distress, fatigue, and physical function are associated with social functioning and interventions targeting these symptoms may help to improve SF among long-term cancer survivors treated with HSCT as AYAs.
OBJECTIVE: Hematopoietic stem cell transplantation (HSCT) can compromise long-term health and social functioning. We examined the impact of physical and social-emotional factors on the social functioning of long-term adolescent and young adult (AYA) HSCT survivors. METHODS: This cross-sectional analysis included HSCT recipients from the INSPIRE trial [NCT00799461] who received their first transplant between ages 15-39. Patient-reported outcome measures included the Short Form-36v2, Fatigue Symptom Inventory, Cancer and Treatment Distress, and the ENRICHD Social Support Inventory. We used hierarchical multiple linear regression to identify physical and social-emotional factors associated with social functioning at the baseline assessment, with the first block including sociodemographic and clinical factors significant at P = <0.10 in univariate testing, the second block including fatigue and physical function, and the third block including social support and distress. RESULTS:Participants (N = 279) were 52% male and 93.5% white, non-Hispanic, with a mean age of 30.3 (SD 6.6) at first transplant. Social Functioning mean was 48.5 (SD 10.5), below age-adjusted norms (t = -13.6, P = <0.001). In the first block, current chronic graft-vs-host disease accounted for 5.5% of the variance (P = <0.001). Adding fatigue and physical function explained an additional 46.6% of the variance (P = <0.001). Adding distress and social support explained an additional 7.7% of the variance (P = <0.001). The final model explained 59.8% of the variance; distress, fatigue, and physical function were significantly associated with social functioning. CONCLUSIONS: Distress, fatigue, and physical function are associated with social functioning and interventions targeting these symptoms may help to improve SF among long-term cancer survivors treated with HSCT as AYAs.
Keywords:
AYA; adolescent and young adult; cancer; cancer survivorship; distress; fatigue; hematologic malignancy; hematopoietic stem cell transplantation; psycho-oncology; social functioning
Authors: Kristin Pulewka; Daniel Wolff; Philipp Y Herzberg; Hildegard Greinix; Pia Heussner; Friederike H A Mumm; Stephanie von Harsdorf; Kathrin Rieger; Philipp Hemmati; Andreas Hochhaus; Inken Hilgendorf Journal: J Cancer Res Clin Oncol Date: 2017-04-19 Impact factor: 4.553
Authors: Jimmie C Holland; Barbara Andersen; William S Breitbart; Luke O Buchmann; Bruce Compas; Teresa L Deshields; Moreen M Dudley; Stewart Fleishman; Caryl D Fulcher; Donna B Greenberg; Carl B Greiner; George F Handzo; Laura Hoofring; Charles Hoover; Paul B Jacobsen; Elizabeth Kvale; Michael H Levy; Matthew J Loscalzo; Randi McAllister-Black; Karen Y Mechanic; Oxana Palesh; Janice P Pazar; Michelle B Riba; Kristin Roper; Alan D Valentine; Lynne I Wagner; Michael A Zevon; Nicole R McMillian; Deborah A Freedman-Cass Journal: J Natl Compr Canc Netw Date: 2013-02-01 Impact factor: 11.908
Authors: Karen L Syrjala; Steven K Sutton; Heather S L Jim; Jennifer M Knight; William A Wood; Stephanie J Lee; Paul B Jacobsen; Muneer H Abidi; Jean C Yi Journal: Cancer Date: 2016-11-28 Impact factor: 6.860
Authors: Anna Spathis; Sara Booth; Sarah Grove; Helen Hatcher; Isla Kuhn; Stephen Barclay Journal: J Adolesc Young Adult Oncol Date: 2015-03 Impact factor: 2.223
Authors: Eden R Brauer; Huibrie C Pieters; Patricia A Ganz; Wendy Landier; Carol Pavlish; MarySue V Heilemann Journal: J Adolesc Young Adult Oncol Date: 2017-06-08 Impact factor: 2.223
Authors: Annemarie M J Braamse; Jean C Yi; Otto J Visser; Martijn W Heymans; Berno van Meijel; Joost Dekker; Karen L Syrjala Journal: Biol Blood Marrow Transplant Date: 2015-12-11 Impact factor: 5.742
Authors: D M Hann; P B Jacobsen; L M Azzarello; S C Martin; S L Curran; K K Fields; H Greenberg; G Lyman Journal: Qual Life Res Date: 1998-05 Impact factor: 4.147
Authors: Jennifer M Knight; Mallory R Taylor; Kelly E Rentscher; Elisabeth C Henley; Hannah A Uttley; Ashley M Nelson; Lucie M Turcotte; Natalie S McAndrew; Hermioni L Amonoo; Lathika Mohanraj; Debra Lynch Kelly; Erin S Costanzo Journal: Front Immunol Date: 2022-07-05 Impact factor: 8.786
Authors: Anne Sophie Lind Helligsoe; Kathrine Synne Weile; Line Kenborg; Louise Tram Henriksen; Yasmin Lassen-Ramshad; Ali Amidi; Lisa Maria Wu; Jeanette Falck Winther; Line Pickering; René Mathiasen Journal: Front Neurosci Date: 2022-02-22 Impact factor: 4.677